Indonesia
· Delayed Price · Currency is IDR PT Kimia Farma Tbk Statistics
Total Valuation
PT Kimia Farma Tbk has a market cap or net worth of IDR 4.01 trillion. The enterprise value is 11.68 trillion.
| Market Cap | 4.01T |
| Enterprise Value | 11.68T |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Kimia Farma Tbk has 5.57 billion shares outstanding. The number of shares has increased by 0.08% in one year.
| Shares Outstanding | 5.57B |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.44% |
| Float | 566.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| PB Ratio | 0.73 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.91 |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -54.37 |
Financial Position
The company has a current ratio of 0.61, with a Debt / Equity ratio of 131.47.
| Current Ratio | 0.61 |
| Quick Ratio | 0.32 |
| Debt / Equity | 131.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -36.29 |
| Interest Coverage | -2.88 |
Financial Efficiency
Return on equity (ROE) is -27.65% and return on invested capital (ROIC) is -7.71%.
| Return on Equity (ROE) | -27.65% |
| Return on Assets (ROA) | -6.37% |
| Return on Capital (ROIC) | -7.71% |
| Revenue Per Employee | 955.22M |
| Profits Per Employee | -157.82M |
| Employee Count | 11,461 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.76% in the last 52 weeks. The beta is 0.22, so PT Kimia Farma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -16.76% |
| 50-Day Moving Average | 655.60 |
| 200-Day Moving Average | 807.13 |
| Relative Strength Index (RSI) | 56.10 |
| Average Volume (20 Days) | 9,554,190 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Kimia Farma Tbk had revenue of IDR 10.23 trillion and -1,690.59 billion in losses. Loss per share was -303.75.
| Revenue | 10.23T |
| Gross Profit | 2.55T |
| Operating Income | -1,919.27B |
| Pretax Income | -2,522.67B |
| Net Income | -1,690.59B |
| EBITDA | -1,459.58B |
| EBIT | -1,919.27B |
| Loss Per Share | -303.75 |
Balance Sheet
The company has 542.50 billion in cash and 7.80 trillion in debt, giving a net cash position of -7,257.67 billion or -1,303.79 per share.
| Cash & Cash Equivalents | 542.50B |
| Total Debt | 7.80T |
| Net Cash | -7,257.67B |
| Net Cash Per Share | -1,303.79 |
| Equity (Book Value) | 5.93T |
| Book Value Per Share | 990.52 |
| Working Capital | -3,518.31B |
Cash Flow
In the last 12 months, operating cash flow was 473.04 billion and capital expenditures -687.96 billion, giving a free cash flow of -214.92 billion.
| Operating Cash Flow | 473.04B |
| Capital Expenditures | -687.96B |
| Free Cash Flow | -214.92B |
| FCF Per Share | -38.61 |
Margins
Gross margin is 24.93%, with operating and profit margins of -18.76% and -16.52%.
| Gross Margin | 24.93% |
| Operating Margin | -18.76% |
| Pretax Margin | -24.65% |
| Profit Margin | -16.52% |
| EBITDA Margin | -14.26% |
| EBIT Margin | -18.76% |
| FCF Margin | -2.10% |
Dividends & Yields
PT Kimia Farma Tbk does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.08% |
| Earnings Yield | -42.19% |
| FCF Yield | -5.36% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |